IMPACT BIOMEDICAL INC

IBONYSE AMERICAN

🏆 #3622 by market capUS Equity

$0.43▼ $0.01 (−1.26%)

Market closed · at close

1h—

24h▼ 1.3%

7d▼ 1.9%

14d▼ 5.5%

30d▼ 5.5%

1y▼ 24.5%

🏦Market Cap

$46M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

1204.0x

Expensive

Otter Score

Weak

Trading Snapshot

Day Range: $0.43 – $0.44
52-Week Range: $0.37 – $0.83
Volume: $1.66B
Avg Volume: $1.16B
Shares Outstanding: 107.8M
Next Earnings: Oct 6, 2026

Fundamentals Snapshot

Annual Revenue: $32,000
Last Q Revenue: $3,000
P/E Ratio: —
P/S Ratio: 1204.0x
EPS (TTM): $-1.26
Dividend Yield: —

Why Investors Own IBO

✓High-growth profile — revenue up -9.8% YoY with expanding US Equity exposure.
✓Healthy economics — 64% gross margin and 9% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$32,000▼ −9.8% YoY

Gross Margin (TTM)

63.5%▲ +3.6% YoY

Operating Income (TTM)

$4,256▼ −9.8% YoY

Free Cash Flow (TTM)

$3,008▼ −9.8% YoY

About IMPACT BIOMEDICAL INC

Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.

🦦